Novavax
NVAX
#5566
Rank
โ‚ฌ1.08 B
Marketcap
6,67ย โ‚ฌ
Share price
-3.99%
Change (1 day)
23.16%
Change (1 year)

Novavax (NVAX) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : โ‚ฌ1.12 Billion

According to Novavax's latest financial reports the company's total liabilities are โ‚ฌ1.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novavax - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ1.11 B-47.11%
2024-12-31โ‚ฌ2.09 B-7.72%
2023-12-31โ‚ฌ2.27 B-15.66%
2022-12-31โ‚ฌ2.69 B4.29%
2021-12-31โ‚ฌ2.58 B232.94%
2020-12-31โ‚ฌ0.77 B142.36%
2019-12-31โ‚ฌ0.32 B-2.48%
2018-12-31โ‚ฌ0.32 B-2.46%
2017-12-31โ‚ฌ0.33 B-11.38%
2016-12-31โ‚ฌ0.38 B345.16%
2015-12-31โ‚ฌ85.39 M123.9%
2014-12-31โ‚ฌ38.13 M65.15%
2013-12-31โ‚ฌ23.09 M38.19%
2012-12-31โ‚ฌ16.71 M70.52%
2011-12-31โ‚ฌ9.8 M-17.47%
2010-12-31โ‚ฌ11.87 M8.68%
2009-12-31โ‚ฌ10.92 M-50.94%
2008-12-31โ‚ฌ22.27 M15.21%
2007-12-31โ‚ฌ19.33 M-8.5%
2006-12-31โ‚ฌ21.12 M-27.94%
2005-12-31โ‚ฌ29.31 M-11.05%
2004-12-31โ‚ฌ32.96 M-13.93%
2003-12-31โ‚ฌ38.29 M-19.01%
2002-12-31โ‚ฌ47.28 M5.4%
2001-12-31โ‚ฌ44.86 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
โ‚ฌ55.77 B 4,837.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ105.13 B 9,206.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ56.60 B 4,910.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ52.67 B 4,563.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚ฌ1.91 B 69.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ48.34 M-95.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ0.44 B-60.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚ฌ1.02 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.54 B-51.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.76 B-32.64%๐Ÿ‡บ๐Ÿ‡ธ USA